Galen resolves patent challenge with Barr

Craigavon-based pharmaceutical firm Galen has settled its patent litigation with Barr Pharmaceuticals.

The deal allows Barr to launch generic versions of Galen's Estrostep oral contraceptive and femhrt hormone therapy products under a non-exclusive license six months prior to patent expiry.